TNF-α/IL-6 regulate glymphatic clearance of amyloid-β and tau. Inhibiting these cytokines impairs waste clearance in AD brains while providing anti-inflammatory benefits in cardiovascular tissues that don't rely on glymphatic function.
Curated pathway from expert analysis
flowchart TD
A["TNF-alpha IL-6 Signaling in AD<br/>Astrocyte Reactivity"]
B["AQP4 Aquaporin-4 Regulation<br/>Astrocytic Endfeet Polarization"]
C["Glymphatic Flow Rate<br/>Interstitial Fluid Exchange"]
D["Amyloid-beta Tau Clearance<br/>Waste Transport to Lymphatics"]
E["Anti-Cytokine Therapy<br/>TNF-alpha IL-6 Inhibition"]
F["AQP4 Perivascular Expression Altered<br/>Glymphatic Function Impaired"]
G["Amyloid-beta Tau Accumulate<br/>Reduced Clearance Rate"]
H["AD Pathology Worsened<br/>Sleep-Dependent Clearance Disrupted"]
A --> B
B --> C
C --> D
E -.->|"disrupts AQP4 regulation"| B
E --> F
F --> G
G --> H
style B fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
style H fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9aNo linked papers recorded for this hypothesis yet.
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for AQP4.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.